Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)

Entrada Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $620000.0 for Q3 2025.

• In Q3 2025, Current Taxes fell 72.46% year-over-year to $620000.0; the TTM figure through Sep 2025 stood at $620000.0 (down 72.46% YoY), while the FY2024 annual figure was $667000.0, down 83.42% from the prior year.
• Current Taxes for Q3 2025 stood at $620000.0, down from $802000.0 in the prior quarter.
• The five-year high for Current Taxes was $7.4 million in Q2 2023, with the low at $620000.0 in Q3 2025.
• The 3-year median for Current Taxes is $3.1 million (2023), against an average of $3.2 million.
• The sharpest annual moves came in 2024 and 2025: Current Taxes tumbled 44.14% in 2024, then sank 86.3% in 2025.
• Entrada Therapeutics' Current Taxes stood at $4.0 million in 2023, then tumbled by 83.42% to $667000.0 in 2024, then fell by 7.05% to $620000.0 in 2025.
• Business Quant data shows TRDA's Current Taxes at $620000.0 in Q3 2025, $802000.0 in Q1 2025, and $667000.0 in Q4 2024.